ARIA Peptide
Intelligence

65 peptides. 9 categories. 15+ clinical tools. One platform.

0
Peptides
0
Categories
0
Clinical Tools
Scroll to explore

The Library

65 peptides, each meticulously profiled with evidence grading, mechanism of action, dosing protocols, regulatory status, and key literature citations.

AOD-9604

MetabolicEmerging

AOD-9604 + GHRP Stack

MetabolicEmerging

Acetyl Tetrapeptide-3

Skin / AestheticExp.

Adipotide

MetabolicExp.

Ala-GHK Copper Peptide

Anti-AgingClinical

Amycretin

MetabolicExp.

Argireline

Skin / AestheticClinical

BPC-157

RegenerationEmerging
65Peptides
Metabolic (9)Skin / Aesthetic (7)Anti-Aging (6)Regeneration (6)Hormonal (12)Sexual Wellness (3)Neuroprotection (8)Muscular (7)Immune (7)

Decision Engine

AI-powered clinical decision support. Input patient profile, conditions, and safety flags — receive ranked, evidence-backed peptide recommendations with contraindication warnings.

👤
Patient ProfileStep 1

Age, weight, conditions

📋
ConditionsStep 2

28 clinical conditions

⚠️
Safety FlagsStep 3

Contraindications, medications

🎯
Ranked ResultsStep 4

Scored & evidence-graded

EvidenceSafetyConfidence
91
Condition Rules
19
Contra Rules
3
Score Weights

Synergy Map

See how peptides work together — and where caution is needed. 65+ relationship edges mapping synergistic pairings and interaction warnings across the entire library.

CJC-1295IpamorelinBPC-157TesamorelinEpitalonThymosin α1SelankTB-500PT-141GHK-CuSynergyCaution

Synergistic Pairings

CJC-1295 + Ipamorelin amplifies GH pulsatility. BPC-157 + TB-500 accelerates tissue repair through complementary pathways.

Caution Zones

Concurrent GH secretagogues may amplify IGF-1 elevation. Immunomodulators near neuroactives require careful timing.

65+ Relationships

Every connection is backed by published research. Tap any edge to see supporting citations and clinical notes.

Case Simulator

Real-world patient scenarios with full clinical narratives, timeline charts, before/after outcomes, and key learnings. 6 case studies across recovery, weight management, aesthetics, and more.

Regeneration

Post-Lipo Recovery

Full recovery in 6 weeks

TimelineOutcomesLearnings
Metabolic

Weight Optimization

-12 lbs in 12 weeks

TimelineOutcomesLearnings
Skin / Aesthetic

Skin Rejuvenation

Visible improvement at 8 wks

TimelineOutcomesLearnings
Hormonal

GH Optimization

IGF-1 +45% at 12 weeks

TimelineOutcomesLearnings
Immune

Immune Optimization

NK cell activity +30%

TimelineOutcomesLearnings
Muscular

Joint Recovery

Pain score -60% at 8 weeks

TimelineOutcomesLearnings

Lab Monitoring

Safety is non-negotiable. Track key biomarkers across the protocol timeline, flagging values that drift outside normal ranges with actionable alerts.

IGF-1
245100-300 ng/mL
normal
Glucose (fasting)
10870-100 mg/dL
elevated
HbA1c
5.9%< 5.7%
elevated
CBC (WBC)
7.24.5-11.0 K/µL
normal
Liver (ALT)
427-56 U/L
normal
Creatinine
1.40.7-1.3 mg/dL
flagged

Lab Order Timeline

Week 0✓ Done
Week 2✓ Done
Week 4✓ Done
Week 6✓ Done
Week 8Next
Week 12

Patient Management

From the first consult to long-term outcomes — track every touchpoint, protocol history, visit timeline, and weight trends. Nothing falls through the cracks.

Patient Journey

👤
Initial Consult

Goals assessment, history review

📋
Screening Report

Contraindications cleared

🧬
Protocol Assigned

CJC/Ipa + BPC-157 stack

💉
Week 4 Follow-upActive

Adherence check, adjust dosing

🔬
Week 8 Labs

IGF-1, metabolic panel

📊
Outcome Review

12-week comprehensive assessment

Outcome Trends

Patient: J.D. · Protocol: Weight Management

182
W0
180
W2
178
W4
175
W6
172
W8
170
W10
Starting: 182 lbs-12 lbs total
92%
Protocol Adherence
33 of 36 doses administered

Interaction Checker

Cross-reference patient medications against the peptide library. 30+ common medications with severity grading — from "No Known Interaction" to "Contraindicated."

Metformin
caution
Warfarin
contraindicated
Lisinopril
monitor
Atorvastatin
safe
Levothyroxine
monitor
Insulin
caution
Aspirin
safe
Omeprazole
safe

Patient Handouts

Branded, personalized education materials generated in seconds. Dosing schedules, storage instructions, expected effects, and safety information — ready to print or share digitally.

ARIA
Patient Protocol Handout
Patient: J. Doe
Date: Jan 15, 2026

CJC-1295 / Ipamorelin

Growth Hormone Secretagogue Stack

Dosing Schedule
Dose: 100 mcg each
Route: Subcutaneous
Frequency: Once daily
Timing: Bedtime
Duration: 12 weeks
Cycle: 5 on / 2 off
Common Effects
  • • Injection site redness
  • • Mild headache
  • • Flushing
  • • Water retention
Storage
  • • Refrigerate 2-8°C
  • • Protect from light
  • • Use within 28 days
  • • Room temp prep only
ARIA Peptide Intelligence PlatformPage 1 of 2

Follow-Up Schedule

Auto-generated clinical timelines from protocol peptide categories. Baseline, tolerance checks, lab rechecks, and end-of-protocol reviews — all mapped out.

Protocol Timeline

12 WEEKS
Wk 0
Baseline
CBCCMPIGF-1
Wk 1
Tolerance
Wk 2
Early Labs
Glucose
Wk 4
Checkpoint
CMP
Wk 6
IGF-1
IGF-1
Wk 8
Mid-Review
CBCCMP
Wk 12
EOP
Full Panel

Research Feed

Stay current with FDA updates, clinical trial results, and safety alerts — curated for peptide therapy.

FDA
New guidance on compounded peptide regulations
Jan 2026
Trial
Phase II results: oral GLP-1 peptide analog
Dec 2025
Safety
Updated WADA prohibited list for 2026
Nov 2025

Regulatory Dashboard

FDA approval status and WADA compliance at a glance. Every peptide classified for clinical and athletic use.

4
FDA Approved
54
Compounded
7
Experimental
3
WADA Banned

Practice Analytics

Your practice, quantified. Track patient volume, protocol distribution, visit frequency, and outcome metrics — all in one dashboard.

🧬
0
Peptides+25
🧠
0
Decision Rules+91
📋
0
Case Studies+6
⚠️
0
Interactions+30

Platform Growth

40
Feb
45
Mar
50
Apr
55
May
60
Jun
65
Jul

The Complete Workflow

One platform, every step. From discovery to management, ARIA connects the entire clinical workflow into a seamless, intelligent experience.

🔍Discover
📚
Library
65 peptides
📰
Research
FDA & trials
🏛️
Regulatory
FDA & WADA
🔗
Synergy
Interactions
🧬Design
🧠
Decision
AI engine
🧪
Designer
Custom protocols
⚗️
Builder
Composer
📋
Protocols
Stacks
💊
Dosage
Calculator
Screening
Readiness
📡Monitor
🔬
Labs
Biomarkers
⚠️
Interact
Drug check
👥
Patients
Dashboard
📊Manage
📅
Schedule
Timeline
📄
Handouts
Education
🏥
Cases
Studies
📈
Simulator
Outcomes
📊
Analytics
Practice

Ready to Transform Your Practice?

Join the clinicians already using ARIA to deliver evidence-backed peptide therapy with confidence, efficiency, and better patient outcomes.

Evidence-graded · HIPAA-aligned · Continuously updated · Built for clinicians, by clinicians